Ahmed Maizbha Uddin, Li Jian, Zhou Qi Tony
Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.
Monash Biomedicine Discovery Institute, Infection Program and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.
Pharmaceutics. 2024 Mar 12;16(3):389. doi: 10.3390/pharmaceutics16030389.
Accumulation of polymyxins in the lung epithelial cells can lead to increased mitochondrial oxidative stress and pulmonary toxicity. Aminoglycosides and polymyxins are used, via intravenous and pulmonary delivery, against multidrug-resistant Gram-negative pathogens. Our recent in vitro and animal studies demonstrated that the co-administration of polymyxins with aminoglycosides decreases polymyxin-induced pulmonary toxicity. The aim of this study was to investigate the in vitro transport and uptake of polymyxin B and tobramycin in human lung epithelial Calu-3 cells and the mechanism of reduced pulmonary toxicity resulting from this combination. Transport, intracellular localization, and accumulation of polymyxin B and tobramycin were investigated using doses of 30 mg/L polymyxin B, 70 mg/L tobramycin, and the combination of both. Adding tobramycin significantly ( < 0.05) decreased the polymyxin B-induced cytotoxicity in Calu-3 cells. The combination treatment significantly reduced the transport and uptake of polymyxin B and tobramycin in Calu-3 cells, compared to each drug alone, which supported the reduced pulmonary toxicity. We hypothesized that cellular uptake of polymyxin B and tobramycin shared a common transporter, megalin. We further investigated the megalin expression of Calu-3 cells using confocal microscopy and evaluated megalin activity using a megalin substrate, FITC-BSA, and a megalin inhibitor, sodium maleate. Both polymyxin B and tobramycin significantly inhibited FITC-BSA uptake by Calu-3 cells in a concentration-dependent manner. Sodium maleate substantially inhibited polymyxin B and tobramycin transport and cellular accumulation in the Calu-3 cell monolayer. Our study demonstrated that the significantly reduced uptake of polymyxin B and tobramycin in Calu-3 cells is attributed to the mechanism of action that determines that polymyxin B and tobramycin share a common transporter, megalin.
多黏菌素在肺上皮细胞中的蓄积可导致线粒体氧化应激增加及肺部毒性。氨基糖苷类药物和多黏菌素通过静脉注射和肺部给药,用于对抗多重耐药革兰氏阴性病原体。我们最近的体外和动物研究表明,多黏菌素与氨基糖苷类药物联合使用可降低多黏菌素诱导的肺部毒性。本研究的目的是调查多黏菌素B和妥布霉素在人肺上皮Calu-3细胞中的体外转运和摄取情况,以及这种联合用药降低肺部毒性的机制。使用30 mg/L多黏菌素B、70 mg/L妥布霉素以及两者的组合剂量,研究多黏菌素B和妥布霉素的转运、细胞内定位和蓄积情况。添加妥布霉素显著(<0.05)降低了多黏菌素B对Calu-3细胞的细胞毒性。与单独使用每种药物相比,联合治疗显著降低了多黏菌素B和妥布霉素在Calu-3细胞中的转运和摄取,这支持了肺部毒性的降低。我们推测多黏菌素B和妥布霉素的细胞摄取共享一种共同转运体,即巨膜蛋白。我们进一步使用共聚焦显微镜研究了Calu-3细胞的巨膜蛋白表达,并使用巨膜蛋白底物FITC-BSA和巨膜蛋白抑制剂马来酸钠评估了巨膜蛋白活性。多黏菌素B和妥布霉素均以浓度依赖的方式显著抑制Calu-3细胞对FITC-BSA的摄取。马来酸钠显著抑制了多黏菌素B和妥布霉素在Calu-3细胞单层中的转运和细胞蓄积。我们的研究表明,Calu-3细胞中多黏菌素B和妥布霉素摄取的显著减少归因于一种作用机制,即多黏菌素B和妥布霉素共享一种共同转运体,巨膜蛋白。